Skip to main navigation Skip to search Skip to main content

Corrigendum to “Illudin S inhibits p53-Mdm2 interaction for anticancer efficacy in colorectal cancer” [Biomed. Pharmacother. 182 (2025) 117795](S0753332224016822)(10.1016/j.biopha.2024.117795)

Research output: Contribution to journalComment/debate

Abstract

The authors regret <insert corrigendum text>. * Correspondence to: Department of Biomedical Engineering, Institute for Cross-disciplinary Studies, Sungkyunkwan University, Suwon 16419, Republic of Korea. * * Correspondence to: School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea * ** Correspondence to: Department of Chemistry, Sungkyunkwan University, Suwon 16419, Republic of Korea.

Original languageEnglish
Article number117810
JournalBiomedicine and Pharmacotherapy
Volume183
DOIs
StatePublished - Feb 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Corrigendum to “Illudin S inhibits p53-Mdm2 interaction for anticancer efficacy in colorectal cancer” [Biomed. Pharmacother. 182 (2025) 117795](S0753332224016822)(10.1016/j.biopha.2024.117795)'. Together they form a unique fingerprint.

Cite this